Ikarian Capital, LLC Jazz Pharmaceuticals PLC Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Ikarian Capital, LLC holds 41,800 shares of JAZZ stock, worth $5.19 Million. This represents 0.51% of its overall portfolio holdings.
Number of Shares
41,800Holding current value
$5.19 Million% of portfolio
0.51%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding JAZZ
# of Institutions
542Shares Held
59MCall Options Held
125KPut Options Held
58.4K-
Black Rock Inc. New York, NY6.15MShares$763 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.04MShares$749 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.53MShares$314 Million0.72% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.21MShares$275 Million0.67% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.04MShares$253 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $7.78B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...